Gary J. Schiller, MD, a hematologist/oncologist from UCLA Health Jonsson Comprehensive Cancer Center, provides expert perspectives on recent data updates presented at the 2023 ASH Annual Meeting.
EP. 1: Current Treatment Landscape for Patients with Lower-Risk MDS
Gary J. Schiller, MD, a hematologist/oncologist, discusses the current treatment landscape for patients with lower-risk myelodysplastic syndrome [MDS].
EP. 2: MDS: Transfusion Independence Across Different Risk Subgroups in IMerge Phase 3 Trial
Expert perspectives on 2 abstracts presented at ASH 2023 looking at durable continuous transfusion independence and efficacy across different risk subgroups in the IMerge phase 3 trial in MDS.
EP. 3: Impact of Mutational Status on Response in IMerge Phase 3 Study in MDS
An expert on myelodysplastic syndrome discusses the impact of mutational status on response in the IMerge phase 3 study.
EP. 4: Durable Transfusion Independence in Lower-Risk MDS
Gary J. Schiller, MD, reviews recent data on durable transfusion independence for patients with lower-risk MDS in the IMerge phase 3 study and discusses how transfusion frequency affects patient outcomes.
EP. 5: MDS: Patient-Reported Outcomes and Imetelstat Toxicity in IMerge Phase 3 Trial
Dr Schiller reviews data updates from the IMerge phase 3 trial looking at patient-reported outcomes and cytopenias in patients with MDS following imetelstat treatment.
EP. 6: Biomarker Analysis and Patient-Reported Outcomes from COMMANDS Study in MDS
An expert on MDS reviews the biomarker analysis and patient-reported outcomes from the COMMANDS study as well as long-term outcomes from the MEDALIST study.
EP. 7: MDS: Canakinumab Phase 1b/2 Study
A hematologist/oncologist discusses a phase 1b/2 study investigating canakinumab in patients with myelodysplastic syndrome.
EP. 8: Clinical Implications of Recent Data in MDS
Gary J. Schiller, MD, concludes with thoughts on the clinical implications of recent data presented at ASH 2023 on the myelodysplastic syndrome treatment landscape.
2 Commerce Drive Cranbury, NJ 08512